samedan logo
 
 
 
spacer
home > pmps > spring 2019 > pharmaceutical fraud
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Pharmaceutical Fraud

In 2011, a man was jailed for eight years for conducting counterfeit medicine fraud that amounted to a retail value of £4.7 million. As a result of him being able to infiltrate the pharmaceutical supply chain, 25,000 packets of counterfeit medication reached pharmacies and patients all over the UK. These knock-off tablets were used to treat heart disease, pancreatic cancer, and mental illnesses and had none, or only part, of the active ingredient they were supposed to contain. Sadly, this meant that those people’s illnesses were left to take their course.

Unfortunately, while tremendous effort goes into ensuring the effective operation of every pharma supply chain, the losses are staggering. With the global counterfeit drug market worth £154 billion and one million people dying due to fake medicine around the world each year, a reliable supply chain is paramount. Enter: blockchain. While blockchain harnesses a plethora of benefits, addressing its shortcomings is necessary to ensure that implementation of the technology can be utilised to its full effect.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Karim Jawhary is the Senior Industry Director of Life Sciences and Healthcare at Unisys. He brings over 15 years’ experience to the technology industry, with deep expertise in cloud computing, Software-as-a- Service, Big Data, and security solutions. Prior to joining Unisys, Karim served at TIBCO Software as a Senior Account Executive, leveraging the TIBCO connected intelligence cloud to augment business intelligence and agility through analytical insights. He also worked at Akamai Technologies as an Enterprise Account Executive where he built a strong life sciences and healthcare practice. Karim holds a bachelor’s degree in business management from East Stroudsburg University of Pennsylvania, US, and has pursued continuing education in force management, Miller Heiman strategic selling, and Sales Performance International solution selling.
spacer
Karim Jawhary
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Bormioli Pharma runs Envision 2020: A Digital Event to Showcase The New Strategic Directions, Brand-New Product Portfolios and Prototypes

Parma, 24 November 2020 – Bormioli Pharma will showcase its brand-new product portfolios, products and prototypes during “Bormioli Pharma Envision 2020”, a digital event that will take place in the first half of December open to all the stakeholders. The event will be the occasion to get in touch with the leading European pharma packaging manufacturer in glass and plastic in such hectic times for the industry. Even during the Covid-19 pandemic, the company has kept the momentum for its expansion and growth process, finalizing new investments and M&As to enlarge its industrial platform and the products range.
More info >>

White Papers

Key to Outsourcing Method Development and Validation: A Pragmatic Approach

RSSL

In an industry that is seeing an increasing level of work being outsourced, the Contract Research Organisation (CRO) of choice needs to have proven experience in both the pragmatism and flexibility of the method developer’s mind set and a regulatory background in validation. As companies are focussing on achieving ever shorter times of drug to market, it is vital that a tailored, pragmatic approach is adopted when engaging in both method development and validation activities for an Active Pharmaceutical Ingredient (API) or drug product (DP). Although methods still require a high degree of robustness, the overall strategy should encompass a full evaluation of the regulatory requirements applicable to the particular phase of the drug life-cycle; this is pivotal in Key to Outsourcing Method Development and Validation A Pragmatic Approach order to ensure a successful regulatory submission, where the applicant must demonstrate suitable validation of all methods used to support the filing.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement